How much funding has Lungpacer Medical raised?

Lungpacer Medical has raised $12.0M in total funding, most recently a Venture Round.

When was Lungpacer Medical founded?

Lungpacer Medical was founded in 2009.

Where is Lungpacer Medical headquartered?

Lungpacer Medical is headquartered in Vancouver, Canada.

What industry is Lungpacer Medical in?

Lungpacer Medical operates in Critical Care, Medical Devices, Neurostimulation.

How many employees does Lungpacer Medical have?

Lungpacer Medical has 51-200 employees.

Lungpacer Medical

Uniting Science and Care to Transform Outcomes

Vancouver, Canada · Founded 2009 · $12.0M raised

Critical Care

Medical Devices

Neurostimulation

Headquarters: Vancouver
Employees: 51–200
Founded: 2009
Business Model: B2B

Website: lungpacer.com
Total Funding: $12.0M
Last Round: $12.0M Venture RoundMay 2026
Rounds: 3

About

Lungpacer Medical is a leader in neurostimulation technologies for critical care, dedicated to helping patients wean from mechanical ventilation through diaphragm pacing. Founded over 15 years ago (c. 2009), the company's AeroPace System — FDA Premarket Approved in 2024 — uses electrical stimulation of phrenic nerves to rebuild diaphragm strength and reduce ventilator dependency in adult ICU patients. The company received FDA Breakthrough Device designation in 2017 and Emergency Use Authorization during COVID-19. Headquartered in Vancouver, BC, Canada with U.S. offices in Exton, Pennsylvania.

Summary

Lungpacer Medical is a Critical Care company based in Vancouver, Canada, founded in 2009. It has raised $12.0M in total across 3 rounds, most recently a $12.0M Venture Round round in May 2026.

LinkedIn X (Twitter)